We just received data on a new analyst forecast for $CNTA. Rudy Li from Chardan Capital set a price target of 30.0 for CNTA.
To track analyst ratings and price targets for $CNTA, check out Quiver Quantitative's $CNTA forecast page.
$CNTA Price Targets
Multiple analysts have issued price targets for $CNTA recently. We have seen 6 analysts offer price targets for $CNTA in the last 6 months, with a median target of $30.0.
Here are some recent targets:
- Rudy Li from Chardan Capital set a target price of $30.0 on 07/30/2025
- Danielle Brill from Truist Securities set a target price of $30.0 on 07/21/2025
- Ami Fadia from Needham set a target price of $35.0 on 05/28/2025
- Biren Amin from Piper Sandler set a target price of $38.0 on 03/31/2025
- Debjit Chattopadhyay from Guggenheim set a target price of $28.0 on 03/26/2025
- Jeffrey Hung from Morgan Stanley set a target price of $27.0 on 03/07/2025
$CNTA Insider Trading Activity
$CNTA insiders have traded $CNTA stock on the open market 32 times in the past 6 months. Of those trades, 2 have been purchases and 30 have been sales.
Here’s a breakdown of recent trading of $CNTA stock by insiders over the last 6 months:
- ARJUN GOYAL has made 2 purchases buying 462,585 shares for an estimated $5,865,242 and 0 sales.
- SAURABH SAHA (Chief Executive Officer) has made 0 purchases and 8 sales selling 330,000 shares for an estimated $4,745,260.
- GREGORY M WEINHOFF (Chief Business Officer) has made 0 purchases and 6 sales selling 63,236 shares for an estimated $920,977.
- KAREN M. ANDERSON (Chief People Officer) has made 0 purchases and 3 sales selling 37,426 shares for an estimated $698,067.
- IQBAL J HUSSAIN (General Counsel) has made 0 purchases and 8 sales selling 36,000 shares for an estimated $537,559.
- MARIO ALBERTO ACCARDI (President, Orexin Program) has made 0 purchases and 2 sales selling 23,322 shares for an estimated $336,750.
- TIA L BUSH (Chief Technology & Quality Ofc) sold 11,000 shares for an estimated $185,406
- DAVID M CHAO (Chief Administrative Officer) has made 0 purchases and 2 sales selling 7,000 shares for an estimated $120,205.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CNTA Hedge Fund Activity
We have seen 64 institutional investors add shares of $CNTA stock to their portfolio, and 60 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AVORO CAPITAL ADVISORS LLC added 4,050,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $58,239,000
- VIDA VENTURES ADVISORS, LLC removed 3,931,818 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $56,539,542
- PERCEPTIVE ADVISORS LLC removed 3,308,825 shares (-52.1%) from their portfolio in Q1 2025, for an estimated $47,580,903
- HOLOCENE ADVISORS, LP added 2,255,679 shares (+inf%) to their portfolio in Q1 2025, for an estimated $32,436,664
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 1,834,973 shares (+35.8%) to their portfolio in Q1 2025, for an estimated $26,386,911
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,665,352 shares (-48.7%) from their portfolio in Q1 2025, for an estimated $23,947,761
- DEEP TRACK CAPITAL, LP removed 1,350,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $19,413,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
